Remove Acquisition Remove Develop Remove Report Remove Thousand Oaks
article thumbnail

Amgen Completes Onyx Pharmaceuticals Tender Offer

socalTECH

Thousand Oaks-based Amgen reported this morning that it has completed its tender offer for Onyx Pharmaceuticals , and now expects its acquisition to complete today. Amgen is paying $125 per share in cash for publicly held Onyx Pharmaceuticals, a developer of biopharmaceuticals for treating cancer. READ MORE>>.

article thumbnail

Nexsan Updates S-1

socalTECH

In a sign that Thousand Oaks-based Nexsan might be ramping up its IPO efforts again, after a delay last year, the firm filed an updated S-1 this week. The provider of data storage equipment reported that it had net income of $0.5M Year to year revenues were up from the $60.89M the firm reported for its year ended June 30, 2009.

article thumbnail

Nexsan Names Sales Head

socalTECH

Thousand Oaks-based Nexsan, a developer of storage hardware products, has appointed a new Chief Commercial Officer, the firm disclosed Monday. Nexsan said that Michael McGuire has joined the firm, reporting to CEO Philip Black, and will be in charge of worldwide sales, marketing, and business development.

Sales 100